Category: Pharma Industry

GSK Posts 340B Refund Notice on High-Revenue Asthma Treatment

February 6, 2024 Rich Daly, Editor in Chief Views

GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

Drugmaker GlaxoSmithKline has posted another refund notice to 340B providers related to purchases of its high-earning asthma drugs. A Jan. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Highly Anticipated Draft 340B Bill Released by Bipartisan Senate Gang of Six

February 2, 2024 Rich Daly, Editor in Chief Views

The “Group of Six” is expected to announce this week that it plans to release the SUSTAIN Act by the end of the year.

After more than six months of long meetings with stakeholders, a bipartisan group of six senators released draft legislation Friday [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genesis Ruling Creates Legal, Regulatory Uncertainty for 340B, Says Attorney Panel

February 1, 2024 William Newton, Associate Editor/Senior Writer Views

Maureen Testoni, president and CEO of 340B Health, Jason Reddish, a principal at Powers Law, and Ross Margulies, a partner at Foley Hoag, discussed the looming uncertainty in 340B following a key federal district court ruling during the 340B Coalition Winter Conference.

A recent federal district court ruling on the 340B patient definition created a “gray area” for 340B providers and drugmakers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Potential Senate Flip May Increase 340B Scrutiny, But Congressional 340B Action Unlikely in 2024, Say 340B Advocate, Drug Industry Analyst

February 1, 2024 William Newton, Associate Editor/Senior Writer Views

Michael McCaughan, co-founder of Provision Policy, spoke about drug pricing policy at the 340B Coalition Winter Conference.

Congress is unlikely to act on 340B in 2024, but a potential flip of the U.S. Senate could lead to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AIDS Group Holds Protest Against NACHC-PhRMA Partnership

February 1, 2024 Rich Daly, Editor in Chief Views

The AIDS Healthcare Foundation staged a protest over ASAP 340B, an alliance between community health centers and the drug industry, at the 340B Coalition Winter Conference.

As many attendees gathered for lunch outside at the 340B Coalition Winter Conference in San Diego on Tuesday, the AIDS [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospital Critics Ramp Up Efforts on Capitol Hill and in Media

February 1, 2024 Rich Daly, Editor in Chief Views

ASAP 340B is one of multiple critics of hospital participation in 340B to recently increase lobbying and media efforts, including an online advertising campaign pictured above.

Critics of hospital participation in the 340B discount drug program are ramping up efforts, as a bipartisan group of senators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

January 30, 2024 Rich Daly, Editor in Chief Views

Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.

The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Systems, HRSA Spar in Federal Court Over 340B Registration Policy Reversal

January 30, 2024 William Newton, Associate Editor/Senior Writer Views

A hospital association asked the U.S. District Court of the District of Columbia to side with more than 40 health systems that sued federal regulators over a hospital registration policy change.

Forty-four health systems have asked a federal district court to decide, without a full trial, on their lawsuit against federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK, Vertex Offer Refunds to 340B Providers

January 30, 2024 Rich Daly, Editor in Chief Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Amid Possible Coming Enforcement, PhRMA Again Asks Court to Block Louisiana’s 340B Contract Pharmacy Law

January 25, 2024 William Newton, Associate Editor/Senior Writer Views

In a recent federal court filing, Louisiana Attorney General Liz Murrill's office said it had not moved to enforce a state 340B contract pharmacy law.

After Louisiana signaled plans to possibly enforce its state 340B contract pharmacy law, a powerful drug industry trade group has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live